Michelle C. Crank
Allergy and Immunology
11002 Veirs Mill Rd Ste 414
Silver Spring, MD 20902
Silver Spring, MD 20902
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Evaluation of a nanoparticle influenza vaccine in the pig model.
Journal: Vaccine
Published: May 29, 2024
An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults.
Journal: Science translational medicine
Published: April 19, 2023
A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine.
Journal: Science translational medicine
Published: December 21, 2022
Elicitation of pneumovirus-specific B cell responses by a prefusion-stabilized respiratory syncytial virus F subunit vaccine.
Journal: Science translational medicine
Published: June 22, 2022
Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses.
Journal: Immunity
Published: March 07, 2022
Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial.
Journal: The Lancet. Respiratory medicine
Published: January 13, 2021
Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses.
Journal: Immunity
Published: October 09, 2020
Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates.
Journal: Science translational medicine
Published: August 28, 2020
Author Correction: Next-generation influenza vaccines: opportunities and challenges.
Journal: Nature reviews. Drug discovery
Published: June 05, 2020
Last Updated: 09/26/2026